Immune Therapeutics, Inc. Note Agreements

First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022 (Filed With SEC on April 10, 2023)

Convertible Promissory Note in the Principal Amount of $200,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps (Filed With SEC on July 22, 2022)

Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps (Filed With SEC on July 22, 2022)

Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey (Filed With SEC on March 18, 2022)

Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation (Filed With SEC on March 18, 2022)

Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on March 18, 2022)

Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on March 18, 2022)

Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey (Filed With SEC on May 24, 2021)

Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation (Filed With SEC on May 24, 2021)

Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on May 24, 2021)

Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on May 24, 2021)

Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on April 15, 2021)

Securities Purchase Agreement dated as of June 15, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of... (Filed With SEC on June 29, 2020)

Securities Purchase Agreement dated as of May 4, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of $53,000 (Filed With SEC on June 29, 2020)

Convertible Promissory Note dated March 30, 2020 to Redstart Holdings Corp. in the principal amount of $53,000 (Filed With SEC on May 14, 2020)

Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on May 14, 2020)

Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on May 20, 2019)

Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on April 16, 2019)

Promissory Note dated April 5, 2017 to Robert J. Dailey in the principal amount of $150,000 (Filed With SEC on April 2, 2018)

Promissory Note dated February 6, 2017 issued to Phoenix Fund Management, LLC (Filed With SEC on April 2, 2018)

Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $400,000 (Filed With SEC on April 2, 2018)

Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $399,000 (Filed With SEC on April 2, 2018)

Securities Purchase Agreement and Note with Iliad Research & Trading LP dated October 20, 2017 (Filed With SEC on November 14, 2017)

PROMISSORY NOTE SETTLEMENT AGREEMENT (Filed With SEC on March 31, 2015)

Promissory note to Robert J. Dailey, issued March 28, 2014 for $200,000 (Filed With SEC on May 15, 2014)

Promissory note to Robert J. Dailey, issued March 7, 2014 for $200,000 (Filed With SEC on May 15, 2014)

Promissory note to Robert J. Dailey, issued February 6, 2014 for $200,000 (Filed With SEC on May 15, 2014)

Category

Industry

Companies

Contracts

Immune Therapeutics, Inc. Note Agreements